This content is restricted to site members. If you are an existing user, please log in. New users may register below.
South Korea grants approval for emergency use Pfizer’s antiviral Covid pills
(G.N.S) dt. 27 Seoul South Korea has given authorization for emergency use Pfizer’s antiviral pills targeting COVID-19 as the first of its kind to be introduced in South Korea. Pfizer’s oral antiviral treatment, called Paxlovid, is “expected to help prevent serious deterioration of patients admitted to residential treatment centers or